Overview

Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets

Status:
Completed
Trial end date:
2018-12-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the bioequivalece of NPC-12 granules in compare with NPC-12T tablets in Japanese healthy Adults
Phase:
Phase 1
Details
Lead Sponsor:
Nobelpharma
Treatments:
Everolimus
Sirolimus